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TITLE OF CASE Do not include “a case report”
Presumptive buprenorphine associated intra-operative apnoea and prolonged recovery in a giant panda (Ailuropoda melanoleuca) during castration for testicular neoplasia.
SUMMARY Up to 150 words summarising the case presentation and outcome (this will be freely available online)
A 14 year old giant panda presented with unilateral scrotal swelling. Palpation and conscious ultrasound were suggestive of testicular neoplasia. Anaesthesia was required to obtain radiographs and magnetic resonance imaging (MRI). Immobilisation was achieved with ketamine and medetomidine, and anaesthesia was maintained with sevoflurane in oxygen. Tumours were discovered in both testes and castration was performed. Prior to surgery buprenorphine was administered by slow intravenous injection. Apnoea occurred after approximately 10 mcg/kg had been injected so administration was discontinued. Manual ventilation was required for the majority of the general anaesthetic duration. Spontaneous ventilation returned shortly before transfer to the recovery area. Intramuscular atipamezole administration did not induce a normal recovery; the panda remained profoundly sedated. Further atipamezole had no effect. Due to the apnoea associated with buprenorphine administration during general anaesthesia naltrexone was administered resulting in the panda standing within five minutes post injection. 
BACKGROUND Why you think this case is important – why did you write it up?
General anaesthesia or chemical restraint is generally required for detailed physical examination and invasive procedures in giant pandas as they are considered dangerous animals (1). However they can be trained to accept some procedures such as ultrasound examination and some aspects of physical examination conscious (1). In this case general anaesthesia was required due to the length of the proposed procedures, the requirement for no movement during MRI and the potential for surgical intervention. Several anaesthetic protocols are described in the literature for chemical immobilisation of giant pandas however many of these protocols have not been extensively investigated. Protocols described for immobilisation include xylazine and ketamine (1), tiletamine and zolazepam (1), ketamine alone (2), medetomidine and ketamine (3), and dexmedetomidine, tiletamine and zolazepam (4). The combination of medetomidine and ketamine for immobilisation and sevoflurane for maintenance of anaesthesia used in this case (3) has been used successfully several times at our institution. There are few complications reported in the literature relating to anaesthesia in giant pandas. Regurgitation under general anaesthesia has been reported in Ursidae (1) and hypoxaemia (percentage saturation of arterial haemoglobin <90 %) was documented in some pandas shortly after immobilisation and for 10 minutes after monitoring began (4), although these animals were not intubated or supplemented with oxygen. There is minimal literature on analgesia in giant pandas. Analgesics mentioned in the literature for other members of the Ursidae family include oral and subcutaneous carprofen and meloxicam, oral buprenorphine and oral tramadol (5) although the efficacy for these drugs has not been evaluated. This case report highlights a previously unreported potential adverse effect to intravenous buprenorphine administered during general anaesthesia in a giant panda.    
CASE PRESENTATION Presenting features, clinical and environmental history
A 14 year old, 123 kg, intact male giant panda at a local zoo presented with unilateral scrotal swelling with associated alopecia and discomfort. Conscious clinical examination and ultrasound were suggestive of a unilateral testicular tumour. Further diagnostic imaging was required to determine the extent of the tumour and assess possible spread to other organs so that an appropriate treatment plan could be implemented. Chemical restraint was required to facilitate further diagnostic procedures due to the temperament of the animal. Three view thoracic radiographs followed by MRI of the testes and abdomen and repeat testicular ultrasound were undertaken. Immobilisation was achieved by administering 40 mcg/kg medetomidine (BOVA Specials, London, UK) and 3 mg/kg ketamine (Ketamidor, Chanelle Pharma, Hungerford, UK) intramuscularly via a dart gun into the right quadriceps femoris muscles. After 15 minutes the sedation was deemed adequate to safely approach the panda by gently stimulating it with a long handled brush and checking for a response to this stimulation. The panda was placed in sternal recumbency and anaesthesia was induced via a face mask with 6% sevoflurane (Sevoflo, Zoetis, Leatherhead, UK) vaporised in oxygen (4 l/min). The panda’s trachea was intubated with a 14 mm internal diameter endotracheal (ET) tube when there was loss of medial palpebral reflex and jaw tone was absent. Intubation was achieved using a laryngoscope with a 35 cm long Miller blade. Anaesthesia was maintained with sevoflurane in oxygen administered via a semi-closed rebreathing circle system. An 18 gauge intravenous catheter was placed aseptically in the left cephalic vein shortly after intubation. Monitoring initially consisted of respiratory rate, percentage saturation of arterial haemoglobin with oxygen and heart rate via a portable pulse oximeter placed on the panda’s tongue (Masimo RAD-5, Masimo, Basingstoke, UK). Three radiographic views of the thorax were obtained. The panda was then moved into an MRI van equipped with a circle breathing system and placed in dorsal recumbency. The pulse oximeter was not MRI compatible so monitoring at this point consisted of respiratory rate and end tidal carbon dioxide (ETCO2) via sidestream capnography and heart rate via an oesophageal stethoscope. The panda breathed spontaneously throughout the MRI which lasted approximately 45 minutes and revealed bilateral testicular tumours with no apparent metastases to local lymph nodes. The panda was moved into an examination room for ultrasound and bilateral castration. Monitoring consisted of continuous sidestream capnography, end tidal inhalant agent monitoring, pulse oximetry, electrocardiogram and oesophageal temperature (Datex, Ohmeda S/5). Intravenous Hartmann’s solution (Vetivex 11, Dechra, Shrewsbury, UK) was initiated (4 ml/kg/hour). Active warming was begun approximately 30 minutes after moving into the examination room using a forced air warming device (Bair Hugger Model 505, 3M, Bracknell, UK) set at 37 °C placed over the top of the panda. The body temperature ranged from 35.2 °C to 36.1 °C and was 35.7 °C at the end of the procedure. In order to provide analgesia intra and post-operatively meloxicam (Loxicom, Norbrook, Corby, UK) was given intravenously at a dose of 0.2 mg/kg. Approximately 30 minutes after meloxicam administration, buprenorphine (Buprecare, Animalcare, York, UK) at a dosage of 20 mcg/kg was diluted in 10ml of 0.9% saline solution (Vetivex 1, Dechra, Shrewsbury, UK) for slow intravenous injection. Approximately halfway through administration apnoea occurred so injection was terminated with approximately only 10 mcg/kg being given. At the time of buprenorphine injection end tidal concentration of sevoflurane was 1.6 %, ETCO2 was 45 mmHg and palpebral reflex and jaw tone were absent. From the time of buprenorphine administration until the end of the procedure, hypoventilation and hypercapnia (ETCO2 58-75 mmHg) necessitated manual intermittent positive pressure ventilation (IPPV) at a rate of 6-8 breaths per minute. Rare intermittent spontaneous breaths were noted (<1 breath per minute). There were minimal effects on other vital parameters other than a mild decrease in heart rate (55 beats per minute to 48 beats per minute). The remainder of the anaesthetic proceeded without incident. By the conclusion of the anaesthetic period spontaneous breaths had increased to a frequency of 3-5 breaths per minute however hypercapnia remained (ETCO2 58 mmHg). Total anaesthetic time was 6 hours. The panda was moved into a heated recovery area and placed near the edge of the enclosure in left lateral recumbency with a tie placed over the ET tube to allow remote extubation. Oxygen was supplemented via the endotracheal tube until shortly before extubation via a portable circle breathing system at a flow rate of 5 l/min. Atipamezole (Antisedan, Zoetis, Leatherhead, UK) was administered by intramuscular injection at a dosage of 200 mcg/kg shortly after moving into the recovery area. The panda’s trachea was extubated 45 minutes after moving into the recovery area when the swallowing reflex had returned. No attempt was made to stand for another 50 minutes and when the panda finally stood he was very ataxic and not interested in food. Approximately 1 hour after standing the panda was noted to have laid down into lateral recumbency again and appeared profoundly sedated and did not respond to stimulation when prodded with a long handled brush. At this point atipamezole was administered again by intramuscular injection at the same dose with no effect. Due to the possibility that buprenorphine was contributing to the delayed recovery, 1 mg/kg (120 mg) naltrexone (Naltrexil, Wildlife Pharmaceuticals Limited, South Africa) was administered by intramuscular injection 30 minutes after the second dose of atipamezole. Five minutes after naltrexone administration the panda stood up and immediately showed interest in honey.  
INVESTIGATIONS If relevant
When apnoea and hypercapnia were noted the following were considered and ruled out as possible causes:Anaesthetic depthPositioning and adequate functioning of the adjustable pressure limiting (APL) valve and the expiratory unidirectional valveArtefact due to malfunctioning of the capnographySurgical manipulation at the time apnoea occurred Investigations relating to the scrotal swelling in this case consisted of imaging modalities and histopathology.Thoracic radiographs were unremarkable and revealed no specific abnormalities.An MRI study of the caudal abdomen and pelvis was acquired. The left testicle was markedly enlarged with entirely disrupted architecture due to the presence of heterogenous, multilobulated mass lesions which measured up to 9.3 cm in length (refer to figure 1 and figure 2). In addition three small nodules were identified within the right testicle (refer to figure 1 and figure 2). These nodules measured up to 1.1 cm in diameter. There was no evidence of iliosacral lymph node enlargement. Histopathology of the submitted testes revealed a seminoma in the left testicle and 3 Sertoli cell tumours in the right testicle.
DIFFERENTIAL DIAGNOSIS If relevant
Differential diagnosis for intra-operative apnoea included:Drugs administered shortly before apnoea occurredExcessive anaesthetic depthNociceptionEquipment related problems e.g issues with the APL valveDifferential diagnosis considered for the prolonged recovery included:Residual effects of medetomidineResidual effects of buprenorphineHypothermiaHypoxaemiaHypercapniaDifferential diagnosis considered for the testicular swelling after imaging were as follows:Testicular neoplasia – interstitial cell tumour, Sertoli cell tumours, and seminomasGranulomatous diseaseHaematoma



TREATMENT If relevant 
Treatment of the apnoea and hypercapnia was manual intermittent positive pressure ventilation which was provided until the end of the anaesthetic when spontaneous ventilation returned. Treatment of the prolonged recovery consisted of atipamezole administration in the first instance and when this did not work naltrexone was administered. These were given to antagonise sedation associated with the medetomidine and the buprenorphine respectively. Attempts were made to ensure that the recovery area was kept warm including the use of infrared heat lamps.   Treatment of the testicular tumours consisted of bilateral radical orchiectomy to remove the primary tumour via a pre-scrotal inguinal para-sagittal incision starting with the left side which was the grossly affected testicle. The distal tunica vaginalis was dissected and removed and a transfixing ligature was applied, no leakage of abdominal fluid was noted after ligation. Minimal intra-operative haemorrhage was seen and the incisions were closed in 3 layers. 
OUTCOME AND FOLLOW-UP  
The giant panda recovered well in the days following castration and was returned to its normal habitat. The panda ate honey shortly after recovery from anaesthesia and was back on normal rations the following day. Analgesia post-surgery consisted of oral meloxicam for 3 days. Follow up computed tomography of the thorax and abdomen 4 months after castration and repeat abdominal ultrasound 6 months after that revealed no evidence of metastatic disease and the panda was reportedly in good health. General anaesthesia using ketamine and medetomidine for immobilisation and sevoflurane for induction and maintenance was smooth and recovery went without complication for both procedures. 
DISCUSSION Include a very brief review of similar published cases 
There is a lack of extensive literature on anaesthesia in giant pandas and to the authors’ knowledge no reports exist of buprenorphine administration in giant pandas. Anecdotal reports exist of an exaggerated response to oral tramadol administration in a panda, however there are no published reports of opioid sensitivity. The protocol used for immobilisation has been used by our institution several times to anaesthetise giant pandas and was described in a letter to the editor (3). This protocol has consistently provided excellent sedation and recovery after using these drugs has always been smooth and quick, with an average time of 30 minutes between atipamezole injection and standing regardless of the length of general anaesthesia. In this case general anaesthesia was stable with minimal changes to vital parameters up to the point when buprenorphine was administered and severe hypoventilation was noted which suggested an exaggerated response to this drug. Buprenorphine sensitivity was further implicated due to the delayed recovery, this may be supported by the fact that an almost immediate response to naltrexone was noted. Buprenorphine was administered for its long duration of action compared to other available opioids (methadone, pethidine and fentanyl) and its efficacy as an analgesic for moderate pain. Buprenorphine is an opioid which works as a partial agonist at the mu opioid receptor (6). Although no reports exist of the use of this drug in giant pandas there are numerous reports of its safety and efficacy in various companion animal species including cats (7), dogs (8) and horses (9). The intended dose in this case of 20 mcg/kg is a dose that is both licensed and commonly used in companion animal species. However the exaggerated response seen in this giant panda after only 10 mcg/kg meant that administration was stopped at this point. Meloxicam was also used in this case and has been shown to provide adequate analgesia in dogs after ovariohysterectomy (10), however the benefit of multimodal analgesia in treating post-operative pain is known to be very important (11, 12) therefore buprenorphine was administered. It was also anticipated that it would be difficult to assess pain and administer further drugs once the panda was conscious hence the addition of buprenorphine as part of a multimodal approach to analgesia. Administration of buprenorphine by intramuscular injection would have been a good alternative in this case, this would have had the benefit of a slower increase in plasma concentration and a lower peak plasma concentration compared to intravenous administration (13), as a result the risk of apnoea may have been reduced. An additive effect of the buprenorphine on top of the immobilisation drugs was potentially a contributing factor for the hypercapnia and apnoea, however buprenorphine was given over 3 hours after immobilisation and ETCO2 was normal prior to administration so this was deemed less likely. A spermatic cord or intra-testicular nerve block with bupivacaine would have provided excellent intra and post-operative analgesia in this case but unfortunately was not performed. Opioid analgesics acting on mu opioid receptors are known to have multiple side effects of which one of the most common is respiratory depression, this is due to a reduction in the sensitivity of chemoreceptors to hypercapnia and hypoxia (14). However buprenorphine is often thought to have a less profound effect at clinically relevant doses due to it being a partial mu opioid receptor agonist (15). Naltrexone is a long acting competitive opioid antagonist with a duration of action of 48-72 hours in humans (16). Despite the long duration of action in humans and some other species it is worth noting that in dogs the terminal half-life and duration of action of naltrexone is considerably shorter (17) (approximately 1.5 hours). Naltrexone is used frequently in zoo animal anaesthesia to antagonise the narcotic effect of opioids and allow quicker recovery. It is favoured due to its long duration of action which makes it effective against potent opioids such carfentanil with which renarcotisation is commonly seen (18). The pharmacokinetics of naltrexone have been studied in goats immobilised with carfentanil with rapid antagonism seen with intravenous, intramuscular and subcutaneous administration (19). Naloxone, another opioid antagonist, would have been a less appropriate choice in this case due to its shorter duration of action of 30-40 minutes in humans (20) and dogs (17) which would have required a constant rate infusion to be effective (20).Other causes of delayed recovery were considered in this case including the length of the anaesthetic, however on another occasion the anaesthetic time was of a similar duration but no delayed recovery occurred. Time to emergence is known to increase with increasing duration of anaesthesia when using volatile anaesthetic agents (21). However, once a patient has emerged from anaesthesia it is unlikely that residual volatile agent stored in the body would cause an effect-site concentration that could lead to unconsciousness again (21) which is what the authors saw in this case. The anaesthetic time was very long for a variety of reasons. Firstly the panda had multiple diagnostic procedures in different areas of the zoo and had to be moved safely which took a considerable amount of time. Secondly the MRI revealed bilateral testicular tumours which was unexpected and altered the possible treatment options which had to be discussed in detail with all stakeholders prior to the commencement of surgery. Bilateral castration was considered the best option in this case and it was in the best interest of the panda to be done as soon as possible. Hypoventilation could also have prolonged the recovery following maintenance with an inhalational agent as it lengthens the time taken to exhale the anaesthetic and can cause further hypercapnia, both leading to a prolonged time to emergence, although the respiratory rate in recovery had returned to a more normal value, making this possibility less likely. Hypoxaemia was also considered as a possible cause of delayed recovery in this case however oxygen was supplemented until extubation via the ET tube. Placement of a pulse oximeter on the tongue would have provided more information but this was not done due to increased risk to personnel. Hypothermia also potentially contributed to the slow recovery as the temperature at the end of the procedure was 35.7 °C which is low and the effect of hypothermia on recovery time in mammals’ is well documented in the literature (22)...  There is one published report of a seminoma in a 25 year old giant panda. The tumour was similar to those seen in domestic dogs (23). The post-mortem examination carried out 3 years post castration revealed no evidence of metastatic disease. Although the prevalence in pandas is unknown, testicular tumours are a common finding in other veterinary species with one study finding a prevalence of 27% in dogs presenting for post mortem examination with no clinical evidence of testicular tumours (24). In conclusion it is reasonable to assume that there may have been an increased sensitivity to buprenorphine in this giant panda. It is unclear whether this is an individual situation or a generalised sensitivity within the species as no other reports of buprenorphine usage in giant pandas exist. The author’s experience in this case means that the dosage and route of administration should be carefully considered when using buprenorphine during general anaesthesia in giant pandas. 
LEARNING POINTS/TAKE HOME MESSAGES 3 to 5 bullet points – this is a required field
Increased sensitivity to buprenorphine administration may potentially be seen in giant pandas during general anaesthesia.Intravenous injections of drugs in anaesthetised animals should be administered slowly to allow adverse effects to be noticed and acted upon. Naltrexone can potentially antagonise the effects of buprenorphine in giant pandas. 
REFERENCES Vancouver style 
Miller RE, Fowler ME. Fowler’s Zoo and Wildlife Medicine. Volume 8. Amsterdam: Elsevier, 2015Jin Y, Lin W, Huang S, et al. Dental Abnormalities in 8 Captive Giant Pandas (Ailuropoda melanoleuca) in China. J. Comp. Path 2012;146:357-64 Reed F, Gregson R, Girling S, et al. Anaesthesia of a captive, male giant panda (Ailuropoda melanoleuca) [Letter to the editor]. Veterinary Anaesthesia and Analgesia 2012;40:103-4Yipeng J, Qiao Y, Liu X, et al. Immobilization of wild giant panda (Ailuropoda melanoleuca) with dexmedetomidine-tiletamine-zolaepam. Veterinary Anaesthesia and Analgesia 2016;43(3):333-7Bourne DC, Cracknell JM, Bacon HJ. Veterinary issues related to bears (Ursidae). International Zoo Yearbook 2010;44:16-32Peck TE, Hill S. Pharmacology for Anaesthesia and Intensive Care. 3rd Edition. Cambridge: Cambridge University Press, 2008Sramek MK, Haas MC, Coleman GD, et al. The safety of high-dose buprenorphine administered subcutaneously in cats.  J Vet Pharmacol Therap 2015;38:434-42Hunt JR, Grint NJ, Taylor PM, et al. Sedative and analgesic effects of buprenorphine, combined with either acepromazine or dexmedetomidine, for premedication prior to elective surgery in cats and dogs. Veterinary Anaesthesia and Analgesia 2013;40:297-307Taylor PM, Hoare HR, De Vries A, et al. A multicentre, prospective, randomised, blinded clinical trial to compare some perioperative effects of buprenorphine or butorphanol premedication before equine elective general anaesthesia and surgery. Equine Veterinary Journal 2016;48:442-50Leece EA, Brearley JC, Harding EF. Comparison of carprofen and meloxicam for 72 hours following ovariohysterectomy in dogs. Veterinary Anaesthesia and Analgesia 2005;32(4):184-92Helander EM, Menard BL, Homra BK, et al. Multimodal analgesia, Current Concepts, and Acute Pain Considerations. Current Pain and Headache Reports 2017;21(3):1-10Mwangi WE, Mogoa EM, Mwangi JM, et al. A systematic review of analgesia practices in dogs undergoing ovariohysterectomy. Veterinary World 2018;11(12):1725-1735Steagall PVM, Pelligand L, Giordano T, et al. Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats. Veterinary Anaesthesia and Analgesia 2013;40:83-95Van Der Schier R, Roozekrans M, Van Velzen M, et al. Opioid-induced respiratory depression: reversal by non-opioid drugs. F1000 Prime Reports 2014;6:79Cowan A, Doxey JC, Harry EJR. The animal pharmacology of buprenorphine, an oripavine analgesic agent. British Journal of Pharmacology 1977;60:547-54Simpson GK, Jackson M. Perioperative management of opioid-tolerant patients. BJA Education 2017;17(4):124-28Pace NL, Parrish RG, Lieberman MM, et al. Pharmacokinetics of Naloxone and Naltrexone in the dog. The Journal of Pharmacology and Experimental Therapeutics 1979;208(2):254-6O’Dell JH, Kock MD, Thompson PN, et al. Minimum effective naltrexone dose to antagonise etorphine immobilisation and prevent the complications of renarcotisation in domestic goats. Veterinary Record 2017;181:481-6Mutlow A, Isaza R, Carpenter JW, et al. Pharmacokinetics of carfentanil and naltrexone in domestic goats. Journal of Zoo and Wildlife Medicine 2004;35(4):489-96Lynn RR, Galinkin JL. Naloxone dosage for opioid reversal: current evidence and clinical implications. Therapeutic advances in drug safety 2018;9(1):62-88Sinclair RCF, Faleiro RJ. Delayed recovery of consciousness after anaesthesia. Continuing Education in Anaesthesia, Critical Care and Pain 2006;6(3)114-8Pottie RG, Dart CM, Perkins NR, et al. Effect of hypothermia on recovery from general anaesthesia in the dog. Australian Veterinary Journal 2007;85(4):158-62Wildt DE, Zhang A, Zhang H, et al. Giant Pandas Biology, Veterinary Medicine and Management. Cambridge: Cambridge University Press, 2006Grieco V, Riccardi E, Greppi GF, et al. Canine Testicular tumours: a study on 232 dogs. Journal of Comparitive Pathology 2008;138(2-3):86-9
FIGURE/VIDEO CAPTIONS figures should NOT be embedded in this document
Figure 1: Short tau inverse recovery (STIR) dorsal MRI image of both testes: the green arrows indicate heterogenous, hyperintense, multilobulated mass lesions within the left testicle. The yellow arrows indicate small hypointense nodules within the right testicles. Figure 2: T2-weighted dorsal MRI image of both testes: the green arrows indicate heterogenous, hyperintense, multilobulated mass lesions within the left testicle. The yellow arrows indicate small hypointense nodules within the right testicle. 
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